S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
Log in

NASDAQ:IPHS - Innophos Stock Price, Forecast & News

$32.00
+0.07 (+0.22 %)
(As of 12/5/2019 04:00 PM ET)
Today's Range
$31.88
Now: $32.00
$32.02
50-Day Range
$31.82
MA: $32.41
$35.42
52-Week Range
$22.57
Now: $32.00
$37.53
Volume213,693 shs
Average Volume122,129 shs
Market Capitalization$630.11 million
P/E Ratio14.04
Dividend Yield6.01%
Beta1.43
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IPHS
CUSIP45774N10
Phone609-495-2495

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$801.84 million
Cash Flow$4.62 per share
Book Value$17.10 per share

Profitability

Net Income$36.07 million

Miscellaneous

Employees1,485
Market Cap$630.11 million
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable

Receive IPHS News and Ratings via Email

Sign-up to receive the latest news and ratings for IPHS and its competitors with MarketBeat's FREE daily newsletter.


Innophos (NASDAQ:IPHS) Frequently Asked Questions

What is Innophos' stock symbol?

Innophos trades on the NASDAQ under the ticker symbol "IPHS."

How often does Innophos pay dividends? What is the dividend yield for Innophos?

Innophos announced a quarterly dividend on Tuesday, August 6th. Investors of record on Friday, August 23rd will be given a dividend of $0.48 per share on Friday, September 6th. This represents a $1.92 dividend on an annualized basis and a yield of 6.00%. The ex-dividend date is Thursday, August 22nd. View Innophos' Dividend History.

How were Innophos' earnings last quarter?

Innophos Holdings, Inc. (NASDAQ:IPHS) issued its quarterly earnings results on Wednesday, November, 6th. The specialty chemicals company reported $0.45 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.55 by $0.10. The specialty chemicals company had revenue of $189 million for the quarter, compared to analyst estimates of $185.55 million. Innophos had a net margin of 2.82% and a return on equity of 11.56%. The company's revenue for the quarter was down 4.1% compared to the same quarter last year. During the same period last year, the firm earned $0.58 earnings per share. View Innophos' Earnings History.

When is Innophos' next earnings date?

Innophos is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Innophos.

What guidance has Innophos issued on next quarter's earnings?

Innophos issued an update on its third quarter 2019 earnings guidance on Monday, October, 21st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $190-190 million, compared to the consensus revenue estimate of $185.55 million.

What is the consensus analysts' recommendation for Innophos?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innophos in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innophos.

Has Innophos been receiving favorable news coverage?

Press coverage about IPHS stock has been trending somewhat negative on Thursday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Innophos earned a news impact score of -1.6 on InfoTrie's scale. They also gave press coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Innophos.

Are investors shorting Innophos?

Innophos saw a drop in short interest during the month of November. As of November 15th, there was short interest totalling 288,200 shares, a drop of 39.2% from the October 31st total of 474,100 shares. Based on an average daily trading volume, of 162,400 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.5% of the company's stock are sold short. View Innophos' Current Options Chain.

Who are some of Innophos' key competitors?

What other stocks do shareholders of Innophos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innophos investors own include Applied Materials (AMAT), Intel (INTC), Energy Transfer LP Unit (ET), Freeport-McMoRan (FCX), 3M (MMM), Costco Wholesale (COST), Cisco Systems (CSCO), FireEye (FEYE), PepsiCo (PEP) and Alibaba Group (BABA).

Who are Innophos' key executives?

Innophos' management team includes the folowing people:
  • Dr. Kim Ann Mink, Chairman, CEO & Pres (Age 59)
  • Mr. Hermanus Kieftenbeld, Sr. VP & CFO (Age 53)
  • Ms. Sherry Duff, Sr. VP and Chief Marketing & Technology Officer (Age 51)
  • Mr. Joshua Horenstein, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 42)
  • Ms. Amy Hartzell, Sr. VP of Supply Chain & Purchasing (Age 43)

Who are Innophos' major shareholders?

Innophos' stock is owned by a number of of retail and institutional investors. Top institutional investors include State Street Corp (3.10%), Confluence Investment Management LLC (0.76%), Foundry Partners LLC (0.69%), Boston Partners (0.67%), Dalton Greiner Hartman Maher & Co. (0.58%) and Millennium Management LLC (0.43%). View Institutional Ownership Trends for Innophos.

Which institutional investors are selling Innophos stock?

IPHS stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan, Barclays PLC, Boston Partners and Confluence Investment Management LLC. View Insider Buying and Selling for Innophos.

Which institutional investors are buying Innophos stock?

IPHS stock was acquired by a variety of institutional investors in the last quarter, including Foundry Partners LLC, Millennium Management LLC, Dalton Greiner Hartman Maher & Co., California Public Employees Retirement System, Synovus Financial Corp, State Street Corp, Russell Investments Group Ltd. and State of Alaska Department of Revenue. View Insider Buying and Selling for Innophos.

How do I buy shares of Innophos?

Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innophos' stock price today?

One share of IPHS stock can currently be purchased for approximately $32.00.

How big of a company is Innophos?

Innophos has a market capitalization of $630.11 million and generates $801.84 million in revenue each year. The specialty chemicals company earns $36.07 million in net income (profit) each year or $2.28 on an earnings per share basis. Innophos employs 1,485 workers across the globe.View Additional Information About Innophos.

What is Innophos' official website?

The official website for Innophos is http://www.innophos.com/.

How can I contact Innophos?

Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected]


MarketBeat Community Rating for Innophos (NASDAQ IPHS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  323 (Vote Outperform)
Underperform Votes:  320 (Vote Underperform)
Total Votes:  643
MarketBeat's community ratings are surveys of what our community members think about Innophos and other stocks. Vote "Outperform" if you believe IPHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel